SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-015582
Filing Date
2023-09-08
Accepted
2023-09-08 09:12:22
Documents
15
Period of Report
2023-09-08
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K chrs-20230908x8k.htm   iXBRL 8-K 61450
2 EX-99.1 chrs-20230908xex99d1.htm EX-99.1 20624
3 GRAPHIC chrs-20230908xex99d1001.jpg GRAPHIC 10673
  Complete submission text file 0001558370-23-015582.txt   235535

Data Files

Seq Description Document Type Size
4 EX-101.SCH chrs-20230908.xsd EX-101.SCH 4383
5 EX-101.DEF chrs-20230908_def.xml EX-101.DEF 3156
6 EX-101.LAB chrs-20230908_lab.xml EX-101.LAB 16015
7 EX-101.PRE chrs-20230908_pre.xml EX-101.PRE 11308
9 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20230908x8k_htm.xml XML 4855
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 231243803
SIC: 2836 Biological Products, (No Diagnostic Substances)